Filed: 5/15/2023ACC: 0001104659-23-060793
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 25 equity positions with a total reported market value of $512.17M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
25
Positions
$512.17M
Total AUM (reported)
54.97M
Total Shares
Allocation by class
COM$437.01M85.3%
SPONSORED ADS$29.42M5.7%
ORDINARY SHARES$28.10M5.5%
ORD SHS$15.88M3.1%
COM NEW$1.75M0.3%
Portfolio Concentration
Top 3$169.88M33.2%
4–10$207.37M40.5%
11–25$134.92M26.3%
Top 3 weight
33.2%
Top 10 weight
73.7%
Voting Authority Distribution
Total shares with voting rights: 54.97M
Sole
Full voting authority
54.97M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole25
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings25
Rows:
VIRIDIAN THERAPEUTICS INC
SOLEShares2.70M
TypeSH
Market value$68.68M
13.41%
Sole
2.70M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares4.88M
TypeSH
Market value$52.71M
10.29%
Sole
4.88M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares2.21M
TypeSH
Market value$48.49M
9.47%
Sole
2.21M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares3.62M
TypeSH
Market value$42.86M
8.37%
Sole
3.62M
Shared
0.00
None
0.00
PLIANT THERAPEUTICS INC
SOLEShares1.43M
TypeSH
Market value$38.04M
7.43%
Sole
1.43M
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares3.30M
TypeSH
Market value$29.42M
5.74%
Sole
3.30M
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares3.52M
TypeSH
Market value$28.10M
5.49%
Sole
3.52M
Shared
0.00
None
0.00
DICE THERAPEUTICS INC
SOLEShares819K
TypeSH
Market value$23.46M
4.58%
Sole
819K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares2.92M
TypeSH
Market value$22.93M
4.48%
Sole
2.92M
Shared
0.00
None
0.00
MERUS N V
SOLEShares1.23M
TypeSH
Market value$22.56M
4.41%
Sole
1.23M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares2.11M
TypeSH
Market value$21.58M
4.21%
Sole
2.11M
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares833.93K
TypeSH
Market value$16.82M
3.28%
Sole
833.93K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares1.97M
TypeSH
Market value$16.32M
3.19%
Sole
1.97M
Shared
0.00
None
0.00
VECTIVBIO HLDG AG
SOLEShares1.87M
TypeSH
Market value$15.88M
3.10%
Sole
1.87M
Shared
0.00
None
0.00
ANNEXON INC
SOLEShares3.22M
TypeSH
Market value$12.40M
2.42%
Sole
3.22M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares6.35M
TypeSH
Market value$12.39M
2.42%
Sole
6.35M
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares2.21M
TypeSH
Market value$8.70M
1.70%
Sole
2.21M
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares1.04M
TypeSH
Market value$8.42M
1.64%
Sole
1.04M
Shared
0.00
None
0.00
THESEUS PHARMACEUTICALS INC
SOLEShares770K
TypeSH
Market value$6.84M
1.34%
Sole
770K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares3.05M
TypeSH
Market value$5.64M
1.10%
Sole
3.05M
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares1.31M
TypeSH
Market value$3.73M
0.73%
Sole
1.31M
Shared
0.00
None
0.00
LYRA THERAPEUTICS INC
SOLEShares924.17K
TypeSH
Market value$1.86M
0.36%
Sole
924.17K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$1.75M
0.34%
Sole
1M
Shared
0.00
None
0.00
RALLYBIO CORP
SOLEShares268.53K
TypeSH
Market value$1.53M
0.30%
Sole
268.53K
Shared
0.00
None
0.00
AFFIMED N V
SOLEShares1.43M
TypeSH
Market value$1.07M
0.21%
Sole
1.43M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VIRIDIAN THERAPEUTICS INCSOLE | COM | 2.70M | SH | $68.68M 13.41% | 2.70M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 4.88M | SH | $52.71M 10.29% | 4.88M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 2.21M | SH | $48.49M 9.47% | 2.21M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 3.62M | SH | $42.86M 8.37% | 3.62M | 0.00 | 0.00 |
PLIANT THERAPEUTICS INCSOLE | COM | 1.43M | SH | $38.04M 7.43% | 1.43M | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | SPONSORED ADS | 3.30M | SH | $29.42M 5.74% | 3.30M | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 3.52M | SH | $28.10M 5.49% | 3.52M | 0.00 | 0.00 |
DICE THERAPEUTICS INCSOLE | COM | 819K | SH | $23.46M 4.58% | 819K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 2.92M | SH | $22.93M 4.48% | 2.92M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 1.23M | SH | $22.56M 4.41% | 1.23M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 2.11M | SH | $21.58M 4.21% | 2.11M | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 833.93K | SH | $16.82M 3.28% | 833.93K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 1.97M | SH | $16.32M 3.19% | 1.97M | 0.00 | 0.00 |
VECTIVBIO HLDG AGSOLE | ORD SHS | 1.87M | SH | $15.88M 3.10% | 1.87M | 0.00 | 0.00 |
ANNEXON INCSOLE | COM | 3.22M | SH | $12.40M 2.42% | 3.22M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 6.35M | SH | $12.39M 2.42% | 6.35M | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 2.21M | SH | $8.70M 1.70% | 2.21M | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 1.04M | SH | $8.42M 1.64% | 1.04M | 0.00 | 0.00 |
THESEUS PHARMACEUTICALS INCSOLE | COM | 770K | SH | $6.84M 1.34% | 770K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 3.05M | SH | $5.64M 1.10% | 3.05M | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 1.31M | SH | $3.73M 0.73% | 1.31M | 0.00 | 0.00 |
LYRA THERAPEUTICS INCSOLE | COM | 924.17K | SH | $1.86M 0.36% | 924.17K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 1M | SH | $1.75M 0.34% | 1M | 0.00 | 0.00 |
RALLYBIO CORPSOLE | COM | 268.53K | SH | $1.53M 0.30% | 268.53K | 0.00 | 0.00 |
AFFIMED N VSOLE | COM | 1.43M | SH | $1.07M 0.21% | 1.43M | 0.00 | 0.00 |